A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis
Launched by E-DA HOSPITAL · Jan 18, 2019
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new magnetic device designed to help manage a condition called blepharoptosis, which is when one eyelid droops lower than the other. The goal of the study is to see how well this device works and whether it is safe for patients. Researchers will be looking at things like how much the eyelid can be lifted, if the device causes any blurry vision or discomfort, and if it leads to any skin irritation around the eye.
To participate in the trial, you need to be at least 18 years old and have drooping of only one eyelid. However, if you have had previous surgery on your eyelid or have certain mental health conditions that affect your ability to follow instructions, you won't be eligible. While the trial is currently active, it's not accepting new participants at this time. If you do participate, you can expect to be closely monitored for any changes or side effects while using the device.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with ptosis; they are capable of understanding and complying with protocol requirements
- • Aged 18 years old or older
- Exclusion Criteria:
- • Upper eyelid scar, contracture, or fibrosis due to previous surgical intervention(s)
- • Patients with psychiatric (or mental) disorders; they are unable to cooperate or follow the study procedure
- • Children younger than 18 years of age
About E Da Hospital
E-Da Hospital is a leading medical institution dedicated to advancing healthcare through innovative clinical research and trials. With a commitment to patient safety and ethical standards, the hospital fosters a collaborative environment that integrates cutting-edge technology with comprehensive medical expertise. E-Da Hospital focuses on a wide range of therapeutic areas, aiming to improve treatment outcomes and enhance the quality of life for patients. Through its robust clinical trial program, the hospital actively contributes to the development of new therapies and interventions, ensuring that the latest advancements in medicine are accessible to the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Kaohsiung, , Taiwan
Patients applied
Trial Officials
Yuan-Kun Tu
Study Chair
E-Da Hospital, Kaohsiung, Taiwan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials